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Fundi
Normal.
Micro-aneurysms, punctate and blotch haemorrhages,
discrete exudates.
Many micro-aneurysms and punctate haemorrhages,
occasional blotch haemorrbages.
TABLE U
Many mk,ro·aneurysm.~and punctate ha,emorrhages plus
occasional blotch haemorrhage.
Fundi


















All samples laken fasting.
Two diabetic cases are described who have developed
retinopathy while under effective control on tolbutamide
therapy. In the one case diabetes has been present for a
period of 2 years and in the other for a period of 7 month .
In case ] control of the diabetes has been very good on a
regime of tolbutamide plus diet. In pite of this, retinopathy
has appeared and advanced rapidly. In case 2 the control
has not been as good as in tbe former, but there has been no
glycosuria and the blood sugar bas not been markedly raised.
Retinopathy is one of the very di tres ing late mani-
DISCUSSION
originally there has been a gradual drop to near normal limits.
Control has not been so good as in Case 1, but the blood sugars
have been returning to near normal levels and this patient is
under effective diabetic control. In spite of her improved con-
dition and the disappearance of all symptoms, retinal changes
have appeared.
The first signs of the changes were noted in January 1958,
when micro-aneurysms and punctate and blotch haemorrhages
were discovered. These have remained constantly present during
the past few months.
Mrs. F.E., aged 68 years. Diabetes mellitus was discovered
in June 1957, her first symptoms being mistiness of vision, thirst
and loss of weight. Early lenticular changes were present in both
eyes; although arteriosclerotic changes were seen there was no
evidence of diabetic retinopathy. A further independent oph-
thalmic opinion 3 months later confirmed the first findings.
Tolbutamide therapy was commenced on 13 June 1957. It
will be seen in Table Jl that although the blood sugar was high
CASE 2
high, being245 mg. per 100 m!. both in July and September 1956.
The fund.i remained normal throughout.
In October 1956 she was transferred to tolbutamide therapy.
Her blood sugar responded immediately and has remained at
near normal Limits since 1hat time (Table I). In spite of the marked
improvement in the diabetic state and 1he fact that she was per-
fectly well, gradual changes occurred in the eye grounds from
January 1958 onwards. At first only a few micro-aneurysms and
occasional punctate and blo1Ch haemorrhages made their appear-
ance but within a matter of a few months the condition had
worsened considerably until it was that ofan advanced retinopathy
with micro-aneurysms, punctate and blotch haemorrhages
and discrete exudates throughout both fundi. ]n June 1958
a slight improvement in the retinopathy was noted, but the
condition still remain very marked.
A great deal of interest has been stimulated in the treatment
of diabetes mellitus as the result of the introduction of the
sulphonyl ureas during the past 3 years. One of these sub-
stances (tolbutamide, D 860), has proved effective1 , 2 in
over 40 % of the middle-old-age group. The patients who
have responded to treatment have been kept under good
control so far as blood sugar and urine estimations have
shown. They have remained symptom-free and have felt well.
However, the great challenge in treatment of diabetes still
remains that of the occurrence of the late manifestations of
the disease. Vascular changes, hypertension, albuminuria,
retinopathy, possibly cataract, and Dupuytren's contraction
have all been described in this category.
Even where good control of diabetes has been maintained
with insulin therapy, the late manifestations have ultimately ap-
peared. It was hoped that with tolbutamide therapy this would
not occur. While realizing that a long period of time must
elapse before it will be possible to evaluate the true effects
of tolbutamide therapy, we feel that it is important to report
any late manifestations occurring during the course of treat-
ment.
One of us (L.M.) has made repeated ophthalmological
examinations of tolbutamide-treated patients at the Diabetic
Clinic, particular attention being paid to the development of
retinopathies or other ocular changes occurring during the
course of therapy. As a result it is now possible to record 2
cases in which retinopathies have occurred during treatment.
CASE I
Mrs. I.J.CM., aged 61 years, presented with diplopia to the
right due to a right external rectus palsy. On investigation she
was found to be diabetic, with a heavy glycosuria and a fasting
blood sugar of 257 mg. per 100 m!. On diet plus IS U. of lente
insulin the patient became asymptomatic and the rectus palsy
































BlOOd sugar expressed in mg. per 100 ml. blood. All samples taken fasting
except those marked •• which were random samples taken 3 hours after a meal.
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festations of the disease. While no claims have been made
that tolbutamide would prevent the on et of thi condition
or other late manifestation of diabetes, it was hoped that
effective control with this remedy might have this result.
The 2 cases described, however, suggest that this is not the
case.
The high incidence of retinopathy in diabetes is well
known. The longer the duration of diabetes the higher would
appear to be the incidence. Waite and Beetham' state that
59 % of their patients with diabetes of 15 year' standing or
more have retinopathy, and Wagener5 that 60% of more
than 10 years standing show a similar condition. Whittington
and Lawrence" state that 75 % with diabetes of 20 years'
standing or more show retinal changes, and Ballantyne7
found 31'7% of cases with retinopathy among 561 diabetics
of all ages. Wagener" gives a figure of 30·6 for diabetic
retinopathy among patients of all ages. One of us (T.S.p
found 58 cases of retinopathy among 231 diabetics, 14 of
whom showed the condition 0-5 years after the diabetes had
commenced.
It is evident that retinopathy may occur early in the course
of diabetes, and Wagener" has pointed out that in occasional
cases of retinopathy the only evidence of diabetes is a 'positive
glucose-tolerance curve. He has suggested that 'a primary
disturbance of carbohydrate metabolism is requisite to the
institution of the retinopathy, but that this disturbance need
not be sufficiently severe to cause permanent elevation of the
blood-sugar levels, and that some secondary defect of meta-
bolism may be the actual cause of the retinopathy'.
On the other hand, Fisher9 states that the principal factor
responsible for the development of diabetic retinopathy is
long-standing hyperglycaemia, and the best method available
at present for the prevention of the degenerative compli-
cations of diabetes is exact control of the diabetes through
training of the diabetics themselves. Dunloplo maintained 39
diabetics on a 'free diet' for 9 years and degenerative com-
plications, including retinopathy, developed in 14 (36 %).
In a group of 15-31 years duration he found retinopathy in
44 % of those with good control and in 79 % of those with
poor control. He has decided that careful control and aggres-
sive treatment of the diabetes over the years are most
important factors in the prevention or postponement of
diabetic degenerative lesions.
It is therefore controversial whether good control of
diabetes is the answer to the problem of the prevention of
retinopathy and the other diabetic degenerative lesions.
Close similarity has been found between the lesions in
diabetic retinopathy and those in the Kimmelstiel-Wil on
syndrome. Further, both the retinopathy and the renal lesions
have been produced in alloxan-diabetic animals by injecting
corticotrophin." It has been observed in our clinic that
patients experiencing emotional upsets (e.g. the loss of a
husband) have had a marked exacerbation of their retino-
pathy, which may be due to an outpouring of cortisome
during a stress period. Thus the possibility that a hormonal
disturbance may be a factor in the causation of the retino-
pathy cannot be discounted.
It would therefore appear that something more than the
effective control of diabetes will be necessary before the
elimination of the late manifestations of diabetes becomes
possible. Whilst patients are symptomatically better under
good control they continue to be dogged by the spectre of
the late manifestations.
Good control was maintained with tolbutamide in 42· 9 %
of cases in a middle- to old-aged group at our clinic, and a
further 28·3 % were kept under fair control. 2 The drug has
now been used at the clinic for almost 2 years without any
serious toxic effects and it can therefore be considered a
valuable addition to our armamentarium in the fight against
diabetes mellitus. However. the appearance of cases of
retinopathy in the effectively treated group suggests that it
will be necessary to continue looking for factors others than
hyperglycaemia in its causation and possibly in the occurrence
of other late manifestations.
SUMMARY
1. Two cases of diabetes mellitus are described who have
developed retinopathy while on tolbutamide therapy.
2. In one case diabetic control was good and in the other
it was fair.
3. The question of the occurrence of retinopathy in
relationship to the control of diabetes is discussed.
4. The suggestion is made that some other factor besides
hyperglycaemia may be the cause of diabetic retinopathy and
possibly other late manifestations of diabetes.
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ISLET-CELL ADENOMA OF THE PANCREAS
REPORT OF A CASE
M. B. MERLIN, M.B., B.CH., D.P.M. and W. J. BUGNAULT, M.B., CH.B., D.P.M.
Komani Hospital, Queenstown
An adenoma of the islet-eells of the pancreas was first reported
by Nicholls in 1902 a a post-mortem finding but no clinical
details of the case were recorded. Harris formulated the
concept of hyperinsulinism in 1924, 3 years after Banting
and Best isolated insulin. In 1927 Wilder and his co-workers
were the first to demonstrate an insulin-secreting tumour.
The first successful removal of an adenoma was undertaken
by Graham in 1929. The diagnostic triad is associated with
the names of Whipple and Frantz (1935). This consists
of the development of hypoglycaemic symptoms after
prolonged fasting or exercise, the dropping of the blood-sugar
level below 50 mg. % and the relief of symptoms by the
